or Try an Advanced Search...

    Technical Analysis for TSVT - 2seventy bio, Inc.

    Grade Last Price % Change Price Change
    F 4.05 5.19% 0.20
    TSVT closed up 5.19 percent on Monday, July 1, 2024, on approximately normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Flat Down Up
    Historical TSVT trend table...
    Date Alert Name Type % Chg
    200 DMA Resistance Bearish 0.00%
    Crossed Above 20 DMA Bullish 0.00%
    MACD Bullish Signal Line Cross Bullish 0.00%
    Up 3 Days in a Row Strength 0.00%
    NR7 Range Contraction 5.19%
    Inside Day Range Contraction 5.19%
    Oversold Stochastic Weakness 5.19%
    Shooting Star Candlestick Bearish 7.71%
    Pocket Pivot Bullish Swing Setup 7.71%
    Doji - Bearish? Reversal 7.71%
    Older End-of-Day Signals for TSVT ...

       Recent Intraday Alerts

    Alert Time
    Up 1 ATR about 9 hours ago
    200 DMA Resistance about 9 hours ago
    Rose Above 200 DMA about 10 hours ago
    Up 5% about 10 hours ago
    10 DMA Support about 10 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    TSVT Chart by TradingView
    Basic chart:

    Profile

    2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts. 2seventy bio, Inc. operates independently of bluebird bio, Inc. as of November 4, 2021.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Cancer Life Sciences Gene Therapy Multiple Myeloma Breakthrough Therapy Chimeric Antigen Receptor T Cell

    Is TSVT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 27 Novo Nordisk buys 2seventy bio’s Hemophilia A program
    Jun 26 2seventy bio Announces Sale of Hemophilia A Candidate and MegaTAL In Vivo Gene Editing Technology to Novo Nordisk for up to $40 million
    Jun 6 Goldman cuts 2seventy bio to neutral, cites competition concerns
    May 8 2seventy bio, Inc. (TSVT) Q1 2024 Earnings Call Transcript
    May 8 2seventy bio GAAP EPS of -$1.01 misses by $0.20, revenue of $12.4M misses by $1.69M
    May 8 2seventy bio Reports First Quarter Financial Results and Recent Operational Progress
    May 7 2seventy bio Q1 2024 Earnings Preview
    May 3 2seventy bio to Report First Quarter 2024 Financial Results on May 8, 2024
    Apr 25 Bristol-Myers posts Q1 beat despite growth headwinds
    Apr 5 Bristol Myers, 2seventy bio's Abecma approved for earlier line multiple myeloma
    See more TSVT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.29
    52 Week Low 1.535
    Average Volume 574,442
    200-Day Moving Average 4.06
    50-Day Moving Average 4.32
    20-Day Moving Average 3.98
    10-Day Moving Average 3.83
    Average True Range 0.28
    RSI (14) 49.49
    ADX 9.7
    +DI 24.46
    -DI 19.39
    Chandelier Exit (Long, 3 ATRs) 3.79
    Chandelier Exit (Short, 3 ATRs) 4.39
    Upper Bollinger Bands 4.42
    Lower Bollinger Band 3.53
    Percent B (%b) 0.58
    BandWidth 22.30
    MACD Line -0.16
    MACD Signal Line -0.18
    MACD Histogram 0.022
    Fundamentals Value
    Market Cap 205.03 Million
    Num Shares 50.6 Million
    EPS -3.77
    Price-to-Earnings (P/E) Ratio -1.07
    Price-to-Sales 2.08
    Price-to-Book 0.99
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.52
    Resistance 3 (R3) 4.49 4.32 4.44
    Resistance 2 (R2) 4.32 4.20 4.33 4.41
    Resistance 1 (R1) 4.18 4.13 4.25 4.21 4.39
    Pivot Point 4.01 4.01 4.04 4.02 4.01
    Support 1 (S1) 3.87 3.89 3.94 3.90 3.71
    Support 2 (S2) 3.70 3.82 3.71 3.69
    Support 3 (S3) 3.56 3.70 3.66
    Support 4 (S4) 3.59